December 7, 2018
Pfizer Japan and Fuji Pharma announced on December 6 that Fuji Pharma will take over the Japanese marketing authorization for the antiepileptic agents Gabapen Tablets and Syrup (gabapentin), from Pfizer. The transfer is expected in FY2019, and Pfizer will continue...read more